NFX

NFX is a leading seed-stage fund. Its returns depend on their portfolio companies raising the next round, so for them, pitch decks aren't a marketing line. They're a direct pathway to how the fund performs.

We met directly with founders and the GP who selected them, and drilled down into what they were building, who they were, and what the biggest challenge was. Drawing from our knowledge and experience, we used rapid learning to break down their technology and adapt it into clear, concise presentations that worked for sophisticated investors.

We brought the patient back into biotech pitches. We broke down the Use of Funds into something a partner could digest in ten seconds. We adapted each presentation into something individually designed, not just a template — but we gave them a template, so they could continue their story without relying on us.

For two years we were the exclusive pitch deck specialist for their fundraising team, creating pitch decks for seed to Series C raises. We covered cybersecurity, biotech, food technology, fintech, and AI. We designed the presentations for the NFX 2024 and 2025 AGM, and internal financial presentations.

Two years, over 70 decks. That's more than the average bear, and we were glad to be there.